Literature DB >> 12398228

Prostate-specific antigen is increased in female patients with Cushing's disease.

L Manetti1, I Lupi, F Bogazzi, G Pellegrini, A Precisi, L Grasso, C Nencetti, M Gasperi, E Martino.   

Abstract

Prostate-specific antigen (PSA) is a serine protease with chymotripsine-like enzymatic activity, produced primarily by the prostate gland. It is widely used as a marker of androgen sensitive-prostate cancer. Likewise, women with androgen-dependent hirsutism have increased serum PSA levels. The aim of the present study was to investigate whether female patients with Cushing's disease had increased serum PSA concentrations. We studied 22 patients with active Cushing's disease. Twelve out of 22 patients were also evaluated after remission of the disease. Forty normal women with no signs of hirsutism served as controls. Mean serum PSA levels were higher in patients with active Cushing's disease than controls (p=0.005). Mean serum PSA levels decreased after remission of the disease (33.7+/-63.3 pg/ml vs 2.2+/-3.0 pg/ml, p<0.002, in active and cured patients, respectively). All patients with high serum PSA levels had a normalization of this parameter after the disease was cured. Serum T, DHEAS and delta4 concentrations decreased after the remission of Cushing's disease. A positive correlation was found between serum PSA and T values (r=0.6, p<0.05). In conclusion, elevated serum PSA values are markers of androgen activity in female with Cushing's disease and their normalization may represent an additional index of remission of the disease.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12398228     DOI: 10.1007/BF03345504

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  10 in total

1.  Adrenocorticotropin levels do not change during early recovery of transsphenoidal surgery for ACTH-secreting pituitary tumors.

Authors:  F R Pimentel-Filho; A Cukiert; F Miyashita; M K Huayllas; M Knoepfelmacher; L R Salgado; B Liberman
Journal:  J Endocrinol Invest       Date:  2001-02       Impact factor: 4.256

2.  Differential steroid hormone regulation of human glandular kallikrein (hK2) and prostate-specific antigen (PSA) in breast cancer cell lines.

Authors:  A Magklara; L Grass; E P Diamandis
Journal:  Breast Cancer Res Treat       Date:  2000-02       Impact factor: 4.872

3.  Antiandrogen drugs lower serum prostate-specific antigen (PSA) levels in hirsute subjects: evidence that serum PSA is a marker of androgen action in women.

Authors:  C Negri; F Tosi; R Dorizzi; A Fortunato; G G Spiazzi; M Muggeo; R Castello; P Moghetti
Journal:  J Clin Endocrinol Metab       Date:  2000-01       Impact factor: 5.958

Review 4.  New biological functions of prostate-specific antigen?

Authors:  E P Diamandis; H Yu
Journal:  J Clin Endocrinol Metab       Date:  1995-05       Impact factor: 5.958

5.  Prostate-specific antigen and human glandular kallikrein 2 are markedly elevated in urine of patients with polycystic ovary syndrome.

Authors:  C V Obiezu; A Scorilas; A Magklara; M H Thornton; C Y Wang; F Z Stanczyk; E P Diamandis
Journal:  J Clin Endocrinol Metab       Date:  2001-04       Impact factor: 5.958

6.  Prostate-specific antigen in female serum, a potential new marker of androgen excess.

Authors:  D N Melegos; H Yu; M Ashok; C Wang; F Stanczyk; E P Diamandis
Journal:  J Clin Endocrinol Metab       Date:  1997-03       Impact factor: 5.958

7.  Measurement of prostate-specific antigen in serum as a screening test for prostate cancer.

Authors:  W J Catalona; D S Smith; T L Ratliff; K M Dodds; D E Coplen; J J Yuan; J A Petros; G L Andriole
Journal:  N Engl J Med       Date:  1991-04-25       Impact factor: 91.245

8.  Human androgen receptor binding to the androgen response element of prostate specific antigen.

Authors:  M C Luke; D S Coffey
Journal:  J Androl       Date:  1994 Jan-Feb

Review 9.  Molecular forms of prostate-specific antigen and the human kallikrein gene family: a new era.

Authors:  R T McCormack; H G Rittenhouse; J A Finlay; R L Sokoloff; T J Wang; R L Wolfert; H Lilja; J E Oesterling
Journal:  Urology       Date:  1995-05       Impact factor: 2.649

10.  The increased circulating prostate-specific antigen concentrations in women with hirsutism do not respond to acute changes in adrenal or ovarian function.

Authors:  H F Escobar-Morreale; J Serrano-Gotarredona; S Avila; J Villar-Palasí; C Varela; J Sancho
Journal:  J Clin Endocrinol Metab       Date:  1998-07       Impact factor: 5.958

  10 in total
  2 in total

1.  Serum prostate-specific antigen concentration is increased in acromegalic women.

Authors:  L Manetti; I Lupi; M Genovesi; L Morselli; L Grasso; C Nencetti; M Gasperi; F Bogazzi; L Bartalena; E Martino
Journal:  J Endocrinol Invest       Date:  2004 Jul-Aug       Impact factor: 4.256

2.  Serum prostate specific antigen levels in women with polycystic ovary syndrome and the effect of flutamide+desogestrel/ethinyl estradiol combination.

Authors:  M Bahceci; M Bilge; A Tuzcu; S Tuzcu; S Bahceci
Journal:  J Endocrinol Invest       Date:  2004-04       Impact factor: 4.256

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.